StockData
Veradermics, Inc logo

Veradermics, Inc (MANE) income statement

MANENYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 7/30
$119.52−4.87 (-3.92%)

Close on Nov 20, 2026Market cap $4.99BP/E –Yield –

See a number that looks wrong?